The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, introduces the Revamped Pharmaceuticals Technology Upgradation Assistance Scheme to enhance industry capabilities and align with global standards. Its approval follows a thorough review by the Scheme Steering Committee, considering the revised Schedule-M of the Drugs and Cosmetics Rule, 1945.
Key Features of the Revised Scheme
Broadened Eligibility Criteria
- Expanded eligibility to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores requiring technology and quality upgradation.
- Preference for Micro, Small, and Medium Enterprises (MSMEs) to support smaller players in achieving high-quality manufacturing standards.
Flexible Financing Options
- Introduces subsidies on a reimbursement basis over the traditional credit-linked approach.
- Diversifies financing options, facilitating widespread adoption.
Comprehensive Support for Compliance with New Standards
- Supports a broader range of technological upgrades in alignment with revised Schedule-M and WHO-GMP standards.
- Eligible activities include improvements in HVAC systems, utilities, testing laboratories, clean room facilities, etc.
Dynamic Incentive Structure
- Pharmaceutical units meeting turnover criteria eligible for incentives up to Rs. 1.00 crore per unit.
- Incentive structure varies based on turnover, incentivizing growth across different scales of operations.
- Below table explains incentives for companies:
-
| Turnover Range (in Crores) | Incentives |
| Less than Rs. 50.00 crore | 20% of investment under eligible activities |
| Rs. 50.00 crore to less than Rs. 250.00 crore | 15% of investment under eligible activities |
| Rs. 250.00 crore to less than Rs. 500.00 crore | 10% of investment under eligible activities |
State Government Scheme Integration
- Allows integration with state government schemes, enabling additional top-up assistance.
- Aims to maximize support for the pharmaceutical industry in technology upgradation efforts.
Enhanced Verification Mechanism
- Introduces a robust verification mechanism through a Project Management Agency.
- Ensures transparency, accountability, and efficient resource allocation.
Government’s Commitment to Industry Growth
- The reform in the PTUAS Scheme will catalyze the growth of the pharmaceutical industry and enhance its compliance with global manufacturing standards.
- By revamping the scheme, the government reaffirms its unwavering commitment to supporting a critical industry for the nation’s health and well-being, ensuring its competitiveness on the global stage.